X
Xianglong Pan
Researcher at Nanjing Medical University
Publications - 17
Citations - 288
Xianglong Pan is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Adenocarcinoma & Cancer. The author has an hindex of 7, co-authored 14 publications receiving 146 citations.
Papers
More filters
Journal ArticleDOI
Three-dimensional computed tomography bronchography and angiography in the preoperative evaluation of thoracoscopic segmentectomy and subsegmentectomy.
TL;DR: The center has developed a method to separate pulmonary segments from the lobe based on cone-shaped principle, and it is named "Cone-shaped Segmentectomy", which ultimately achieve a completely anatomical segmentectomy.
Journal ArticleDOI
M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942.
R Uribe,Ke Wei,Margath A. Walker,Zijian Ma,Fengming Yang,Xin Zhao,Wei Jiang,Chunfeng Pan,Zhihua Li,Xianglong Pan,Zhicheng He,Jing Xu,Weibing Wu,Yang Xia,Liang Chen +14 more
TL;DR: In this paper, the role of M2 macrophage-derived exosomes in lung adenocarcinoma (LUAD) was investigated both in vivo and in vitro and its underlying mechanism.
Journal ArticleDOI
Exosome-mediated transfer of miR-1260b promotes cell invasion through Wnt/β–catenin signaling pathway in lung adenocarcinoma
Yang Xia,Ke Wei,Liu-Qing Hu,Cun‐Rong Zhou,Zhi‐Bin Lu,Gen‐Sheng Zhan,Xianglong Pan,Chunfeng Pan,Jun Wang,Wei Wen,Jing Xu,Zhicheng He,Chenjun Huang,Liang Chen +13 more
TL;DR: A new regulation mechanism involving in cell invasion by exosome‐mediated tumor‐cell‐to‐tumor‐cell communication is identified and Targeting exosomal‐microRNAs may provide new insights into the diagnosis and treatment of LAC.
Journal ArticleDOI
miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC
Yang Xia,Ke Wei,Feng-Ming Yang,Liu-Qing Hu,Chunfeng Pan,Xianglong Pan,Weibing Wu,Jun Wang,Wei Wen,Zhicheng He,Jing Xu,Xin-Feng Xu,Quan Zhu,Liang Chen +13 more
TL;DR: This study is the first to illustrate that miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate NSCLC cell proliferation and apoptosis, and is a potential biomarker and therapeutic target for NSCLc.
Journal ArticleDOI
Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
Jing Xu,Chengxiang Zhu,Yue Yu,Weibing Wu,Jing Cao,Zhihua Li,Juncheng Dai,Cheng Wang,Yu Tang,Quan Zhu,Jun Wang,Wei Wen,Lei Xue,Fuxi Zhen,Jinyuan Liu,Chenjun Huang,Fei Zhao,Yue Zhou,Zhicheng He,Xianglong Pan,Haixing Wei,Yining Zhu,Yaozhou He,Jun Que,Jinghua Luo,Liang Chen,Wei Wang +26 more
TL;DR: CDCA5 contributed to ESCC progression and might serve as an attractive target for ESCC immunotherapy, and in vivo assay showed that silenced CDCA5 could inhibit tumor growth.